How I do it: Implant-free transposition technique for microvascular decompression in hemifacial spasm Authors: Melanie Kristt, Raymond F Sekula Published: 2026 ABSTRACT AbstractBackground Hemifacial spasm (HFS) is most often caused by arterial compression of the facial nerve (CNVII). Microvascular decompression (MVD) of CNVII has excellent outcomes, achieving spasm freedom in approximately 90% of patients, and can be accomplished by inter positional or transpositional techniques.MethodWe present a step-by-step description of an experienced surgeon’s technique for MVD in HFS using vessel transposition with TachoSil®, supported by an illustrative video.ConclusionIn our experience, transposition using TachoSil® during MVD for HFS, in appropriately selected patients, is a safe and effective approach offering potential advantages over traditional materials and techniques.Supplementary informationThe online version contains supplementary material available at 10.1007/s00701-026-06942-z.Keywords: Hemifacial spasm, Microvascular decompression, Outcomes, TachoSil®, Transposition Introduction and anatomy Hemifacial spasm (HFS), involuntary unilateral facial twitching, is usually caused by arterial compression along the centrally myelinated portion of the facial nerve (CNVII) [7, 10]. Microvascular decompression (MVD) is a highly effective HFS treatment, with > 90% success rate [4]. Decompression can be achieved through interposition, placing inert material between the nerve and vessel, or transposition, mobilizing and securing the vessel away from the nerve [7]. Since its inception, MVD has undergone refinements in visualization tools, decompression materials, and closure techniques. Notably, a recent study found that 96.5% of MVDs used nonabsorbable materials [3], underscoring the prevalence of permanent implants. In contrast, we describe one variation of an experienced surgeon’s implant-free transposition technique for MVD for HFS, using a fully bioabsorbable material. Operative technique Patient selection All patients undergo high-resolution MRI to confirm arterial compression of CNVII, usually by the posterior inferior cerebellar artery (PICA), anterior inferior cerebellar artery (AICA), or vertebral artery (VA) (Fig. 1). Example magnetic resonance images of a patient with right-sided hemifacial spasm. A Preoperative axial SSFP image and (B) coronal SSFP image demonstrating the posterior inferior cerebellar artery (red) compressing the right facial nerve (yellow). C Postoperative axial SSFP image and (D) coronal SSFP image demonstrating that the right facial nerve (yellow) has been completely decompressed Materials Small pieces cut from a standard sheet of TachoSil® Fibrin Sealant Patch (Corza Medical), a collagen matrix coated with human fibrinogen and thrombin, are used in all procedures. Patient position After induction and intubation, the patient is placed in the lateral decubitus position, with all pressure points padded. The vertex of the head is gently depressed 10° for optimal visualization, and the head is stabilized on a soft rest. The patient is secured with straps and/or tape to prevent sliding while the table position is changed. Incision The transverse sinus course is identified by the line connecting the zygoma root and the inion. The posterior margin of the sigmoid sinus is identified by the digastric point [1]. The incision site, about 4 cm in length, is marked inferior to the transverse sinus and medial to the sigmoid sinus (Fig. 2). The hair is clipped, and the area is cleaned with betadine before draping in a sterile manner. An incision is made with a 15-blade scalpel down to the subcutaneous fat, utilizing monopolar cautery to achieve hemostasis. A Weitlaner retractor is introduced, and the fascia and muscles are opened down to the bone. Patient position and skin incision for microvascular decompression. The patient, with left-sided hemifacial spasm, is placed in the right lateral decubitus position, and the head is flexed and secured. The retromastoid incision is delineated Craniectomy A 1.5 × 2 cm burr hole craniectomy is made below the asterion using a high-speed electric drill with a 5 mm coarse diamond drill bit and Kerrison rongeurs to carefully expose the dura. Bone debris is irrigated and removed. An effort is made to avoid the mastoid air cells; if exposed, the air cells are occluded with bone wax. Brainstem auditory evoked potentials (BAEPs) are continuously monitored. The dura is opened with a 15-blade scalpel and reflected with suture. A cotton patty is placed over the cerebellar surface, and the endoscope, exoscope, or microscope is introduced into the field. Cranial nerve exposure, decompression, and closure The arachnoid of the cerebellomedullary cistern is exposed, sectioned, and a copious amount of cerebrospinal fluid is drained to allow for brain relaxation. The arachnoid is opened around the 7th-11th cranial nerves. The offending vessel is identified and separated from CNVII, disturbing CNVII as minimally as possible. If the patient’s vascular anatomy allows, the vessel can be transposed away from CNVII and can be adhered to the petrous dura or another surface, such as the VA, with TachoSil® (Fig. 3). The integrity of the nerve is confirmed by 0.05 mA stimulation of the attached segment of CNVII. Irrigation confirms that the transposed vessel remains secure. A Valsalva maneuver is performed to ensure that there is no occult bleeding. The dura is closed with 4–0 Surgilon™ sutures in a watertight manner, a calcium phosphate cement cranioplasty is achieved [2], and the wound is closed in layers. Intraoperative views. A Prior to microvascular decompression, the posterior inferior cerebellar artery, its perforators, and the anterior inferior cerebellar artery are compressing the left facial nerve. B After decompression, PICA and AICA secured away from the facial nerve with TachoSil® Indications Patients with HFS confirmed by high-resolution MRI may benefit from MVD. If the offending vessel is mobile and anatomy permits adherence to the petrous dura without excessive traction, transposition using TachoSil® can be safe and effective. Additionally, TachoSil® may offer advantages over traditional materials. Unlike polytetrafluoroethylene(PTFE), TachoSil® is bioabsorbable, which can be advantageous in cases of spasm recurrence, as the absence of permanent foreign material may make it easier to assess for recurrent neurovascular conflict on postoperative imaging. PTFE may also be associated with increased scarring around CNVII. Additionally, TachoSil® was originally developed for vascular repair, supporting its safety profile for vessel adherence. These properties position TachoSil® as a practical, versatile material for transposition in MVD. Limitations This technique is not universally applicable. Transposition may be unsafe when the offending vessel is constrained by short brainstem perforators, as mobilization risks perforator avulsion. In these cases, interposition may be the more prudent option. As with all procedures, these decisions must be individualized, considering both the surgeon’s familiarity with the technique and the patient’s specific neurovascular anatomy. Additionally, TachoSil® is approximately 10 × more expensive than PTFE, increasing operative costs. How to avoid complications Continuous BAEP monitoring is recommended to reduce hearing-related morbidity. Continuous BAEP monitoring is recommended to reduce hearing-related morbidity. Before committing to transposition, the surgeon must confirm that the vessel can be mobilized without hazardous tension on perforators. Before committing to transposition, the surgeon must confirm that the vessel can be mobilized without hazardous tension on perforators. Final inspection after irrigation should confirm durable displacement of the vessel and absence of occult hemorrhage. Final inspection after irrigation should confirm durable displacement of the vessel and absence of occult hemorrhage. Calcium phosphate cement cranioplasty may reduce the risk of CSF leak. Calcium phosphate cement cranioplasty may reduce the risk of CSF leak. Specific information for the patient Patients should be counseled that MVD is a well-established operation for HFS and provides a high likelihood (> 90%) of spasm relief [4, 6, 10]. In this variation, the compressing vessel is mobilized away from the facial nerve using a bioabsorbable material rather than a permanent implant. The final decompression strategy is determined intraoperatively based on the patient’s vascular anatomy, and not all patients are suitable candidates for transposition. Risks of the operation, while uncommon, include hearing loss, facial weakness, dizziness, CSF leak, infection, bleeding, lower cranial nerve dysfunction, persistent spasm, or recurrence [7, 10]. Improvement may be immediate, but in some cases relief is delayed. The absence of permanent implant material may also be relevant if re-exploration becomes necessary, as permanent prostheses can contribute to scarring and may complicate assessment of recurrent neurovascular conflict on MRI [5]. 10 key points HFS is usually caused by arterial—most often PICA, AICA, or VA—compression of the centrally myelinated portion of the facial nerve. HFS is usually caused by arterial—most often PICA, AICA, or VA—compression of the centrally myelinated portion of the facial nerve. MVD is the definitive surgical treatment for HFS, with > 90% long-term spasm resolution. MVD is the definitive surgical treatment for HFS, with > 90% long-term spasm resolution. High-resolution preoperative MRI is essential for identifying neurovascular conflict and selecting appropriate patients for MVD. High-resolution preoperative MRI is essential for identifying neurovascular conflict and selecting appropriate patients for MVD. Although most MVDs use permanent foreign material such as PTFE felt, the technique presented here uses TachoSil®, a bioabsorbable, vessel-safe material that may offer advantages over permanent implants. Although most MVDs use permanent foreign material such as PTFE felt, the technique presented here uses TachoSil®, a bioabsorbable, vessel-safe material that may offer advantages over permanent implants. Transposition, with or without TachoSil®, should be performed only when vessel mobility and perforator anatomy permit safe mobilization. Transposition, with or without TachoSil®, should be performed only when vessel mobility and perforator anatomy permit safe mobilization. Interposition is preferable when transposition would risk perforator avulsion. Interposition is preferable when transposition would risk perforator avulsion. Several groups have described TachoSil®-assisted transposition in MVD for HFS, with high rates of spasm relief at long-term follow-up and no increase in adverse events [8, 9], supporting the technique described here. Several groups have described TachoSil®-assisted transposition in MVD for HFS, with high rates of spasm relief at long-term follow-up and no increase in adverse events [8, 9], supporting the technique described here. Prior techniques have used TachoSil® with additional materials such as fibrin glue or muscle; in contrast, our technique is more streamlined and requires fewer materials and steps. Prior techniques have used TachoSil® with additional materials such as fibrin glue or muscle; in contrast, our technique is more streamlined and requires fewer materials and steps. We present a streamlined, practical method for implant-free microvascular decompression of the facial nerve using TachoSil® for vessel transposition, which in our experience is both effective and safe. We present a streamlined, practical method for implant-free microvascular decompression of the facial nerve using TachoSil® for vessel transposition, which in our experience is both effective and safe. Further investigation is needed to validate this technique. Further investigation is needed to validate this technique. Supplementary information Below is the link to the electronic supplementary material. Video 1. This video shows a patient with left-sided hemifacial spasm undergoing implant-free, transpositional microvascular decompression using TachoSil®. First, the patient’s presentation and preoperative imaging are shown. Subsequently, the most critical surgical steps are shown. The arachnoid is opened; the posterior inferior cerebellar artery (PICA) is found to be compressing the central myelinated portion of the facial nerve. PICA is carefully mobilized, transposed, and adhered to the petrous dura with TachoSil®. Next, the anterior inferior cerebellar artery (AICA) is seen contacting the facial nerve and is then transposed and adhered to the vertebral artery with TachoSil®. At the conclusion of the video, a clearly decompressed facial nerve is seen. (MP4 422 MB) Author contribution MK and RFS drafted, reviewed, and revised the manuscript. MK prepared the figures. RFS provided project oversight and supervision. Funding No specific funding was received for this work. Data availability No datasets were generated or analysed during the current study. Declarations Previous presentations None. Previous publications None. Competing interests The authors declare no competing interests. Disclosures The authors have no personal, financial, or institutional interest in any of the materials or devices described in this article. Footnotes Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Video 1. This video shows a patient with left-sided hemifacial spasm undergoing implant-free, transpositional microvascular decompression using TachoSil®. First, the patient’s presentation and preoperative imaging are shown. Subsequently, the most critical surgical steps are shown. The arachnoid is opened; the posterior inferior cerebellar artery (PICA) is found to be compressing the central myelinated portion of the facial nerve. PICA is carefully mobilized, transposed, and adhered to the petrous dura with TachoSil®. Next, the anterior inferior cerebellar artery (AICA) is seen contacting the facial nerve and is then transposed and adhered to the vertebral artery with TachoSil®. At the conclusion of the video, a clearly decompressed facial nerve is seen. (MP4 422 MB) Data Availability Statement No datasets were generated or analysed during the current study.